SUN PHARMACEUTICAL IND L | Stock ComparatorSUN PHARMACEUTICAL IND L
Overview
Strengths
- The company has low debt. Net Debt to EBITDA Ratio is -0.30 and it is lower than the sector mean.
- Strong EBITDA Margin of 32.37%.
Weaknesses
- With a depreciation Potential of -61.13%, based on our fundamental analysis, it suggests the stock may be overvalued.
Key Financial Data
| Indicator | Value |
|---|
| PER | 37.6 |
| EV/EBITDA | 22.6 |
| Price/Free Cash Flow' | 49.0 |
| ROIC | 14.2% |
| Net Debt/EBITDA | -0.3 |